Burn energy expenditure and hypermetabolic physiology

Overview¶

Management of the metabolic response to severe burn injury is a fundamental part of burn care ^[34]. Hypermetabolism is the near-universal physiologic response to a major burn, and major burn patients differ from other critically ill patients in the magnitude and duration of their inflammatory and metabolic responses ^[31]. Where most insults provoke a metabolic surge that resolves within days, a severe burn drives a hypermetabolic response that persists up to two years after the injury ^[1]. Resting energy expenditure roughly doubles, and the patient enters a state of whole-body catabolism, muscle wasting, and severe cachexia ^[2]. The clinical consequence is a patient who is burning through lean tissue at a rate that cutaneous wound closure alone does not reverse, because muscle catabolism persists after severe burn ^[7,35].

This page treats the physiology of that response, how its intensity is measured clinically, and the rationale behind the levers used to blunt it. The specific intervention detail for each pharmacologic lever lives on dedicated sibling pages: [[beta-adrenergic-blockade-propranolol-in-burn-care]], [[anabolic-agents-oxandrolone-gh-igf-testosterone-in-burn]], [[glycemic-control-insulin-resistance-in-burn]], and [[burn-nutrition-enteral-feeding-and-nutrient-supplementation]]. Here the focus stays on the underlying derangement and why each lever works.

Pathophysiology¶

Ebb and flow¶

The metabolic response to a burn is biphasic ^[4]. An initial shock or "ebb" phase is followed by a hypermetabolic, catabolic "flow" phase ^[4]. Jahoor and colleagues quantified this trajectory directly: resting energy expenditure rose above predicted levels by roughly 40% in the acute phase and 50% in the flow phase, then returned toward normal in convalescence ^[5]. The flow phase is a hyperdynamic state, and at its peak the metabolic rate runs at roughly twice normal ^[2]. Unlike the transient response to most injuries, this state can persist for years after the burn, with deleterious downstream consequences for the patient ^[23].

Hormonal drivers¶

The response is hormonally mediated. Plasma catecholamines, cortisol, and glucagon rise by up to 50-fold, and that surge drives whole-body catabolism, elevated resting energy expenditure, and multiorgan dysfunction ^[1]. Catecholamines are the central signal ^[3]. Wilmore's foundational work established that the extent of energy production is positively related to the rate of urinary catecholamine excretion, and that burned patients are internally warm, not externally cold; catecholamines mediate their increased heat production ^[3]. Glucocorticoids contribute substantially: hypercortisolemia has been proposed as a primary hormonal mediator of whole-body catabolism, and in one trial blocking cortisol production normalized an 8-fold elevation in urine cortisol ^[8]. Glucagon drives the elevated glucose production that characterizes the response ^[7]. The endocrine picture is one of sustained "stress" hormone elevation whose catabolic effects scale with the percentage of total body surface area burned ^[6].

Substrate metabolism and muscle¶

The catabolic engine consumes skeletal muscle. After a large burn, muscle functions as an endogenous amino acid store, releasing substrate for more pressing functions such as acute-phase protein synthesis ^[12]. Wolfe's metabolic studies showed that this muscle protein catabolism is accelerated and produces progressive loss of lean body mass that is not prevented by nutritional support alone, because amino acid transmembrane transport kinetics favor efflux ^[7]. Fat metabolism is similarly deranged. Catecholamine-induced lipolysis increases free fatty acid delivery, and with decreased intramuscular beta-oxidation this drives ectopic triglyceride deposition and hepatic steatosis ^[13,14]. The net picture is one of futile substrate cycling rather than efficient fuel use ^[44]. Burned adults show the downstream signature of this state: elevated heart rates, respiratory rates, plasma glucose, and fibrinogen relative to controls ^[15].

Measuring energy expenditure¶

Quantifying a given patient's energy expenditure matters because it sets the nutrition target, and both under- and over-feeding carry consequences. Indirect calorimetry is the only method considered the gold standard for measuring caloric expenditure ^[18]. It derives resting energy expenditure from measured oxygen consumption and carbon dioxide production.

The difficulty is that indirect calorimetry is not universally available, which has driven the proliferation of predictive equations: more than 190 have been described ^[19]. Their accuracy in severe burns is poor ^[17]. A 2024 meta-analysis found that for adult patients with severe burns, all of the commonly used equations for predicting resting energy expenditure are inaccurate, with accuracy below 50%; among them the Toronto equation carried the lowest bias, followed by the Harris-Benedict equation multiplied by 1.5 and the Milner equation ^[17]. The literature converges on indirect calorimetry as the reference standard, with the Toronto, 1.5×Harris-Benedict, or Ireton-Jones equations cited as fallbacks when calorimetry is unavailable ^[19,17]. Equation-based estimates also drift over the hospital course, since the response itself changes with wound healing, so serial reassessment is part of any estimation approach ^[5].

Modulating the hypermetabolic response¶

Attenuating the hypermetabolic response is the unifying goal of metabolic burn care, and the strategies divide into physical and pharmacologic levers. Combining early excision and grafting, thermoregulation, infection control, early continuous enteral nutrition, and pharmacologic treatment has been associated with markedly decreased morbidity ^[1].

Physical and surgical levers¶

Early excision and wound closure is the foundational non-pharmacologic strategy; in pediatric burns, early excision abrogated the hypermetabolic response ^[22]. A warm environment reduces the thermogenic drive: classic anabolic strategy bundles list maintenance of ambient temperature at 30 to 32 degrees Celsius alongside early grafting, sepsis control, high-protein high-carbohydrate enteral feeding, and early aerobic-resistive exercise ^[20]. The evidence base for the temperature target specifically is thin, a point returned to in the controversies section ^[26,27].

Nutrition¶

Nutrition support is both supportive and modulatory. Because catabolism is not prevented by feeding alone, nutrition does not reverse the response but supplies the substrate that limits net loss; protein requirements in this state are met at approximately 1.5 g/kg/day ^[7]. Early enteral feeding has been investigated as a way to blunt the response itself, with promising but inconclusive results ^[33]. The full delivery protocol is treated on [[burn-nutrition-enteral-feeding-and-nutrient-supplementation]].

Pharmacologic levers¶

Four pharmacologic levers recur across the modulation literature, each targeting a different node of the response: ^[6,31]

• Beta-adrenergic blockade (propranolol). Because catecholamines drive the response, non-selective beta-blockade directly opposes its central mediator ^[3]. A meta-analysis found that propranolol significantly decreased resting energy expenditure and trunk fat while improving peripheral lean mass and insulin resistance, and its use appeared safe ^[28]. The full intervention is treated on [[beta-adrenergic-blockade-propranolol-in-burn-care]].
• Anabolic agents (oxandrolone, growth hormone, IGF-1, testosterone). These oppose catabolism by promoting net protein synthesis ^[24]. Restoration of testosterone has been shown to ameliorate the muscle catabolism of severe burn under normal feeding ^[29]. Recombinant human growth hormone, the synthetic testosterone analogue oxandrolone, and related agents are recurrently cited as pharmacologic modulators of the response ^[6]. Detail is on [[anabolic-agents-oxandrolone-gh-igf-testosterone-in-burn]].
• Insulin and glycemic control. Insulin opposes catabolism (it stimulates inward amino acid transport and muscle protein synthesis) and addresses the insulin resistance intrinsic to the response ^[7]. One systematic review supports moderate insulin administration targeting 130 to 150 mg/dL as the prudent approach ^[30]. See [[glycemic-control-insulin-resistance-in-burn]].
• Cost-effective combination. Low-dose insulin infusion, propranolol, and oxandrolone have been described as among the most cost-effective and least toxic of these therapies ^[21].

Complications¶

The hypermetabolic state is itself a source of downstream complications. Stress-induced hyperglycemia is common because hepatic glucose production and catecholamine-mediated glycogenolysis are augmented ^[42]. That hyperglycemia is not benign: it exacerbates muscle protein catabolism, with an association between hyperglycemia and an increased rate of muscle protein catabolism in severely burned patients, likely reflecting muscle insulin resistance ^[9]. The sustained cardiovascular stress produces lasting cardiac strain. In children, heart rate, cardiac output, cardiac index, and rate-pressure product remained significantly elevated for up to two years after injury, indicating vastly increased cardiac stress ^[16]. The lipid derangement carries cardiovascular consequences as well, with the post-burn profile promoting atherogenic dyslipidemia including hepatic steatosis and altered lipoproteins ^[14]. Collectively these metabolic alterations can drive mortality through organ failure even in patients who survive the initial injury ^[37].

Special Considerations¶

Children mount a particularly pronounced and prolonged response. In severely burned children, hypermetabolism and catabolism remain exaggerated for at least nine months after injury ^[35]. The cardiovascular footprint is long: pediatric burn patients often have hypertension and tachycardia for several years, and circulatory effects have been documented for at least three years after injury ^[38,36]. Age and sex modulate the response within the pediatric group. Children under four years of age maintained lean body mass and weight during acute hospitalization, whereas older children lost both ^[39]. Female children mount a lower hypermetabolic response than males, which may favor their outcomes ^[40]. One point of practical note: inhalation injury does not appear to augment the hypermetabolic response in children, as measured by resting energy expenditure and oxygen consumption ^[41].

Outcomes¶

The magnitude of the response is prognostic, and it scales with burn size ^[11]. Burn-size dependence of outcomes begins around 60% TBSA, where morbidity and mortality become driven by the heightened hypermetabolic and inflammatory reaction together with impaired cardiac function ^[11]. Loss of lean body mass is the central outcome the whole field targets, because muscle loss after burn injury is associated with increased mortality and morbidity ^[24]. The persistence of the response is what distinguishes recovery from a burn from recovery from most other critical illness: catabolism continues after wound closure, lean mass takes a sustained hit, and metabolic derangements extend into the post-discharge period, where the effects of most modulating drugs are largely unknown apart from oxandrolone ^[24,43].

Controversies and Evidence Gaps¶

Does modulation change hard outcomes? Several modulators reliably improve metabolic surrogates without demonstrated benefit on mortality or length of stay ^[25]. An updated meta-analysis of beta-blockers found a protective effect on heart rate, resting energy expenditure, and rate-pressure product, but no reduction in mortality, sepsis, or hospital length of stay ^[25]. A pediatric review reached the same conclusion: beta-blockers reduce the hypermetabolic state, but evidence is insufficient to establish an effect on mortality or length of stay ^[32]. The gap between surrogate improvement and outcome benefit is the central unresolved question of the field.

The thermoneutral environment. Elevating ambient temperature is a long-standing recommendation, but the evidence underpinning it is limited, with minimal human studies of physiologic benefit or adverse effects ^[26]. Room-temperature settings across burn units vary widely precisely because evidence-based guidelines are lacking ^[27].

Glycemic targets, especially in children. Moderate glucose control appears safe in adults, but data in children remain uncertain, with a seemingly higher risk of hypoglycemia ^[31]. The optimal target in the pediatric population is unsettled.

Nutrition timing. Whether early enteral feeding blunts the hypermetabolic response itself remains uncertain; results are promising but insufficient to provide clear guidance ^[33].

Drivers of mortality. Whether the excess mortality of large burns is attributable to inflammation, to hypermetabolism, or to other contributing factors is not fully determined ^[11].

References¶

[1] Williams FN, Herndon DN. "Metabolic and Endocrine Considerations After Burn Injury." Clinics in plastic surgery 2017. PMID: 28576243 ↩

[2] Rodriguez NA, Jeschke MG, Williams FN, Kamolz LP, Herndon DN. "Nutrition in burns: Galveston contributions." JPEN. Journal of parenteral and enteral nutrition 2011. PMID: 21975669 ↩

[3] Wilmore DW, Long JM, Mason AD, Skreen RW, Pruitt BA. "Catecholamines: mediator of the hypermetabolic response to thermal injury." Annals of surgery 1974. PMID: 4412350 ↩

[4] Tredget EE, Yu YM. "The metabolic effects of thermal injury." World journal of surgery 1992. PMID: 1290269 ↩

[5] Jahoor F, Desai M, Herndon DN, Wolfe RR. "Dynamics of the protein metabolic response to burn injury." Metabolism: clinical and experimental 1988. PMID: 3282147 ↩

[6] Pereira C, Murphy K, Jeschke M, Herndon DN. "Post burn muscle wasting and the effects of treatments." The international journal of biochemistry & cell biology 2005. PMID: 16109499 ↩

[7] Wolfe RR. "Herman Award Lecture, 1996: relation of metabolic studies to clinical nutrition--the example of burn injury." The American journal of clinical nutrition 1996. PMID: 8901806 ↩

[8] Jeschke MG, et al. "The effect of ketoconazole on post-burn inflammation, hypermetabolism and clinical outcomes." PloS one 2012. PMID: 22606232 ↩

[9] Gore DC, Chinkes DL, Hart DW, Wolf SE, Herndon DN, Sanford AP. "Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients." Critical care medicine 2002. PMID: 12441751 ↩

[10] Hart DW, et al. "Determinants of skeletal muscle catabolism after severe burn." Annals of surgery 2000. PMID: 10998644

[11] Jeschke MG, et al. "Burn size determines the inflammatory and hypermetabolic response." Critical care (London, England) 2007. PMID: 17716366 ↩

[12] Porter C, Herndon DN, Sidossis LS, Børsheim E. "The impact of severe burns on skeletal muscle mitochondrial function." Burns : journal of the International Society for Burn Injuries 2013. PMID: 23664225 ↩

[13] Cree MG, Wolfe RR. "Postburn trauma insulin resistance and fat metabolism." American journal of physiology. Endocrinology and metabolism 2008. PMID: 17957035 ↩

[14] AbuBaha M, et al. "Hypermetabolism and Lipid Alterations Postburn: A Cardiovascular Perspective." Cardiovascular therapeutics 2026. PMID: 41660577 ↩

[15] Martini WZ, et al. "Hypercoagulation and Hypermetabolism of Fibrinogen in Severely Burned Adults." Journal of burn care & research : official publication of the American Burn Association 2020. PMID: 31504640 ↩

[16] Williams FN, et al. "Changes in cardiac physiology after severe burn injury." Journal of burn care & research : official publication of the American Burn Association 2011. PMID: 21228708 ↩

[17] Wang Y, et al. "Estimates of resting energy expenditure using predictive equations in adults with severe burns: A systematic review and meta-analysis." JPEN. Journal of parenteral and enteral nutrition 2024. PMID: 38409876 ↩

[18] Mendonça Machado N, Gragnani A, Masako Ferreira L. "Burns, metabolism and nutritional requirements." Nutricion hospitalaria 2011. PMID: 22470012 ↩

[19] Núñez-Villaveirán T, et al. "[Energy expenditure prediction equations in burn patients; bibliographic review]." Nutricion hospitalaria 2014. PMID: 24972462 ↩

[20] Herndon DN, Tompkins RG. "Support of the metabolic response to burn injury." Lancet (London, England) 2004. PMID: 15183630 ↩

[21] Pereira CT, Herndon DN. "The pharmacologic modulation of the hypermetabolic response to burns." Advances in surgery 2005. PMID: 16250555 ↩

[22] Barret JP, Herndon DN. "Modulation of inflammatory and catabolic responses in severely burned children by early burn wound excision in the first 24 hours." Archives of surgery (Chicago, Ill. : 1960) 2003. PMID: 12578404 ↩

[23] Badoiu SC, et al. "Glucose Metabolism in Burns-What Happens?" International journal of molecular sciences 2021. PMID: 34068151 ↩

[24] Diaz EC, Herndon DN, Porter C, Sidossis LS, Suman OE, Børsheim E. "Effects of pharmacological interventions on muscle protein synthesis and breakdown in recovery from burns." Burns : journal of the International Society for Burn Injuries 2015. PMID: 25468473 ↩

[25] Bhatti A, et al. "The Effectiveness and Safety of Beta Antagonists in Patients With Burns: An Updated Meta-Analysis." The American surgeon 2025. PMID: 39792849 ↩

[26] Rizzo JA, Rowan MP, Driscoll IR, Chan RK, Chung KK. "Perioperative Temperature Management During Burn Care." Journal of burn care & research : official publication of the American Burn Association 2017. PMID: 27294857 ↩

[27] Kinter K, Alfaro R, Sutherland M, McKenney M, Elkbuli A. "The Impact of Ambient Temperature Control Across Various Care Settings on Outcomes in Burn Patients: A Review Article." The American surgeon 2021. PMID: 34382819 ↩

[28] Flores O, Stockton K, Roberts JA, Muller MJ, Paratz JD. "The efficacy and safety of adrenergic blockade after burn injury: A systematic review and meta-analysis." The journal of trauma and acute care surgery 2016. PMID: 26517779 ↩

[29] Ferrando AA, Sheffield-Moore M, Wolf SE, Herndon DN, Wolfe RR. "Testosterone administration in severe burns ameliorates muscle catabolism." Critical care medicine 2001. PMID: 11588456 ↩

[30] Campbell JM, Adanichkin N, Kurmis R, Munn Z. "Intensive insulin therapy, insulin sensitisers and insulin secretagogues for burns: A systematic review of effectiveness and safety." Burns : journal of the International Society for Burn Injuries 2018. PMID: 29029859 ↩

[31] Berger MM, Pantet O. "Nutrition in burn injury: any recent changes?" Current opinion in critical care 2016. PMID: 27314258 ↩

[32] Shan Chew EC, Baier N, Lee JH. "Do β-Blockers Decrease the Hypermetabolic State in Critically Ill Children With Severe Burns?" Hospital pediatrics 2015. PMID: 26231635 ↩

[33] Wasiak J, Cleland H, Jeffery R. "Early versus late enteral nutritional support in adults with burn injury: a systematic review." Journal of human nutrition and dietetics : the official journal of the British Dietetic Association 2007. PMID: 17374019 ↩

[34] Herndon D, Zhang F, Lineaweaver W. "Metabolic Responses to Severe Burn Injury." Annals of plastic surgery 2022. PMID: 35312639 ↩

[35] Hart DW, et al. "Persistence of muscle catabolism after severe burn." Surgery 2000. PMID: 10923010 ↩

[36] Ojeda S, et al. "The Safety and Efficacy of Propranolol in Reducing the Hypermetabolic Response in the Pediatric Burn Population." Journal of burn care & research : official publication of the American Burn Association 2018. PMID: 29757441 ↩

[37] Greabu M, et al. "Drugs Interfering with Insulin Resistance and Their Influence on the Associated Hypermetabolic State in Severe Burns: A Narrative Review." International journal of molecular sciences 2021. PMID: 34575946 ↩

[38] Duke JM, Randall SM, Fear MW, Boyd JH, Rea S, Wood FM. "Long-term Effects of Pediatric Burns on the Circulatory System." Pediatrics 2015. PMID: 26459653 ↩

[39] Jeschke MG, et al. "Age differences in inflammatory and hypermetabolic postburn responses." Pediatrics 2008. PMID: 18310198 ↩

[40] Mlcak RP, Jeschke MG, Barrow RE, Herndon DN. "The influence of age and gender on resting energy expenditure in severely burned children." Annals of surgery 2006. PMID: 16794397 ↩

[41] Przkora R, Fram RY, Herndon DN, Suman OE, Mlcak RP. "Influence of inhalation injury on energy expenditure in severely burned children." Burns : journal of the International Society for Burn Injuries 2014. PMID: 24893760 ↩

[42] Elijah IE, Børsheim E, Maybauer DM, Finnerty CC, Herndon DN, Maybauer MO. "Role of the PPAR-α agonist fenofibrate in severe pediatric burn." Burns : journal of the International Society for Burn Injuries 2012. PMID: 22226866 ↩

[43] Blears E, Ross E, Ogunbileje JO, Porter C, Murton AJ. "The impact of catecholamines on skeletal muscle following massive burns: Friend or foe?" Burns : journal of the International Society for Burn Injuries 2021. PMID: 33568281 ↩

[44] Wise AK, Hromatka KA, Miller KR. "Energy Expenditure and Protein Requirements Following Burn Injury." Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition 2019. PMID: 31418486 ↩